Alaunos Therapeutics, Inc.
USD2.34
-0.03 (-1.34%)
CEO
Holger Weis
IPO Date
2005-08-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.31
Prev. Close
$2.37
Day Low
$2.31
Day High
$2.34
52W Low
$1.67
52W High
$6.20
Market Cap
$0.01B
Volume
0.01M
| -0.7 |
| 31 Dec 2023 | FY | -95960.0% | -702800.0% | -557.2% | -425.3% | 0.00 | 4.22 | -0.5 |
| 31 Dec 2022 | FY | 100.0% | -1291.2% | -97.9% | -58.1% | 0.52 | 2.23 | -3.7 |
| 31 Dec 2021 | FY | 100.0% | -19786.7% | -135.6% | -83.0% | 0.52 | 4.91 | -3.0 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -64.5% | -54.6% | 0.04 | 7.11 | -6.6 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -124.0% | -108.0% | 0.02 | 8.42 | -6.7 |
| 31 Dec 2018 | FY | 100.0% | -36381.5% | -62.1% | -55.9% | 0.00 | 8.89 | -5.1 |
| 31 Dec 2017 | FY | 100.0% | -850.3% | 56.1% | -51.4% | 0.00 | 4.35 | -10.4 |
| 31 Dec 2016 | FY | 100.0% | -2409.2% | 213.8% | -155.4% | 0.00 | 6.63 | -4.2 |
| -1.8 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -41.3% | -31.1% | 0.00 | 2.92 | -1.1 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -28.7% | -22.2% | 0.00 | 3.48 | -1.9 |
| 31 Mar 2025 | Q1 | 100.0% | -53650.0% | -101.4% | -50.6% | 0.00 | 1.00 | -0.5 |
| 31 Dec 2024 | Q4 | 100.0% | -18550.0% | -36.0% | -26.9% | 0.00 | 3.98 | -1.0 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -41.4% | -31.7% | 0.00 | 4.30 | -1.1 |
| 30 Jun 2024 | Q2 | -4400.0% | -28225.0% | -29.9% | -24.1% | 0.00 | 5.16 | -2.3 |
| 31 Mar 2024 | Q1 | -100.0% | -168200.0% | -35.1% | -27.9% | 0.00 | 4.87 | -4.2 |
| 31 Dec 2023 | Q4 | -93200.0% | -784300.0% | -124.4% | -94.9% | 0.00 | 4.22 | -0.5 |